Genmab A (GMAB) Inventory (2023 - 2026)

Genmab A's Inventory history runs 4 years deep, the most recent figure standing at $21.0 million for Q1 2026.

• Quarterly Inventory rose 75.0% year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 million (up 75.0% YoY) and the FY2025 annual result came in at $18.0 million, up 100.0% from the prior year.
• Inventory was $21.0 million for Q1 2026 at Genmab A, up from $18.0 million in the prior quarter.
• Across five years, Inventory topped out at $21.0 million in Q1 2026 and bottomed at $8.0 million in Q4 2023.
• A 4-year average of $13.6 million and a median of $13.0 million in 2025 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory increased 12.5% — and 2025, when it surged 100.0%.
• Genmab A's Inventory stood at $8.0 million in 2023, then gained by 12.5% to $9.0 million in 2024, then jumped by 100.0% to $18.0 million in 2025, then advanced by 16.67% to $21.0 million in 2026.
• Business Quant data shows GMAB's Inventory at $21.0 million in Q1 2026, $18.0 million in Q4 2025, and $14.0 million in Q3 2025.